Archive 2016

2016

- 16 Dec 2016 – 21st Century Cures Act signed into law by President Obama
- 30 Nov 2016 – Destiny Pharma CEO appointed to the board of GAMRIF
- 31 Oct 2016 – Wellcome Trust report on boosting development of new antimicrobial drugs
- Destiny Pharma to attend IDWeek in New Orleans, Louisiana
- 21 Sep 2016 – Momentous Step taken by UN to Fight Antibiotic Resistance welcomed by Destiny Pharma
- 05 Sep 2016 – Press Release: Novel Antibacterial Drug, exeporfinium chloride, Delivers Encouraging Safety, Tolerability and Efficacy Data in US Clinical Trial
- Destiny Pharma Expert View Published in The Pharma Letter
- Destiny Pharma invited to present at the inaugural Superbugs & Superdrugs USA Conference & Exhibition on the 14th and 15th November 2016 in New Jersey, USA
- 19 May 2016 – Destiny Pharma Welcomes O’Neill Report on Tackling Antimicrobial Resistance (AMR)
- 18 Mar 2016 – Destiny Pharma: ‘In the News.’
- 26 Jan 2016 – Destiny Pharma sign Declaration to fight antibiotic resistance